Healthcare >> CEO Interviews >> April 25, 2005
RICHARD GABRIEL is President and Chief Executive Officer of DNAPrint_
genomics, Inc. Mr. Gabriel served as President and Chief Executive
Officer of Calix Corp., parent company to Pharm-Eco Laboratories, Inc.,
from 1998 to 2001. He was instrumental in closing and managing more than
$135 million in contract revenue for Pharm-Eco Laboratories and
successfully completed the formation of numerous joint ventures, limited
liability companies and spin-offs that resulted in several public and
private companies in the genetics/chemistry/pharmaceutical field. From
2001 until joining DNAPrint, Mr. Gabriel consulted for several startup
companies while working as a Partner at Genbiomics, LLC, and as head of
Life Sciences Practice at Semaphore, Inc. Prior to the formation of his
own consulting practice in 1985, he was a Product Manager for W.R.
Grace. Mr. Gabriel obtained his MBA from Suffolk University's Executive
MBA Program, Boston, Massachusetts, in 1985, and a BS in Chemistry from
Ohio Dominican College, Columbus, Ohio, in 1978. Profile
conceptualize the company at this point?
Mr. Gabriel: Dr. Tony Frudakis founded the company in 1999. Tony is a
geneticist
